sxtchina.com (SXTC) - Koefisien utang jangka dawa marang modal

China SXT Pharmaceuticals, Inc. - logo grafis emiten SXTC

China SXT Pharmaceuticals (SXTC) is building a workforce of extraction technologists and chemists, creating a sustainable corporate environment with strong social protections. This chart illustrates the company's price action, which aligns with the 0.02 indicator. The business relies on a symbiosis of classical Eastern medicine and modern pharmacology, valuing the unique expertise of its personnel. Stable demand among the elderly supports the ecosystem, despite government price regulations.

sxtchina.com (SXTC): Utang jangka dawa marang ekuitas saka 04.07.2022 nganti 31.10.2026
Produk mawa merek SXT Pharmaceuticals

Assessing asset resilience requires analyzing the proportion of liabilities with maturities exceeding one year relative to net equity, which allows the long-term debt-to-equity ratio to track default risk or resource underutilization. For China SXT Pharmaceuticals (SXTC), the balance of this coefficient is critical, as the regional specifics of phytopharmaceuticals provide stability but limit opportunities for aggressive leveraged growth.

Analisis perusahaan pesaing

Haleon PLC - Kewajiban jangka dawa marang ekuitas|Utang jangka dawa marang modal KVUE|VRNA (Verona Pharma Inc.) - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang modal MENS (Jyong Biotech Ltd)|Utang jangka dawa marang modal ligand.com LGND|AMRX - Utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal PRGO (Perrigo Company PLC)|Alvotech Corp (ALVO) - Utang jangka dawa marang ekuitas|Rasio utang jangka dawa marang ekuitas Liquidia Inc.|GLPG (Galapagos NV) - Utang jangka dawa marang modal|Utang jangka dawa marang modal anipharmaceuticals.com|Rasio utang jangka dawa marang ekuitas MNKD (MannKind)|AMPH (Amphastar Pharmaceuticals Inc) - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Pacira PCRX|ARS Corp (SPRY) - Kewajiban jangka dawa marang modal|TBPH: Rasio utang jangka dawa marang ekuitas|aquestive.com - Rasio silihan jangka dawa marang modal|SCPH: Utang jangka dawa marang modal|Tectonic Therapeutic - Koefisien utang jangka dawa marang modal|TNXP (Tonix Pharmaceuticals Inc.) - Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal Eupraxia Pharma EPRX|Utang jangka dawa marang ekuitas BioHarvest Sciences (BHST)|EXOZ (invizyne.com) - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang modal ORMP (Oramed Pharmaceuticals Inc.)|ENTX - Rasio utang jangka dawa marang ekuitas|MindWalk - Utang jangka dawa marang modal|Koefisien utang jangka dawa marang modal ABVC (ABVC BioPharma, Inc)|CPIX: Utang jangka dawa marang modal|QNTM - Rasio tanggungan utang jangka dawa marang modal|Utang jangka dawa marang ekuitas FibroGen|Rasio utang jangka dawa marang modal TELO (Telomir Pharmaceuticals Inc)|Utang jangka dawa marang modal RANI|Utang jangka dawa marang modal synergychc.com (SNYR)|Rallybio - Rasio utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal LEXX|PULM - Utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka dawa marang modal Pheton Holdings Ltd PTHL|APM (aptorumgroup.com) - Rasio utang jangka dawa marang ekuitas|Rasio utang jangka dawa marang modal LYRA|Rasio utang jangka dawa marang ekuitas IBO|TNFA (TNF Pharma) - Rasio silihan jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas YCBD (cbdMD, Inc.)|PRFX (PainReform Ltd) - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Altamira Therapeutics Ltd. CYTO|LIPO (Lipella Pharma) - Kewajiban jangka dawa marang ekuitas|OptiNose, Inc. - Utang jangka dawa marang modal|Koefisien utang jangka dawa marang modal PIRS (pieris.com)|PROC: Utang jangka dawa marang modal|Petros Pharmaceuticals Inc (PTPI) - Utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Qilian International Holding Group Limited|SLRN: Koefisien utang jangka dawa marang modal|Utang jangka dawa marang ekuitas TFF Pharmaceuticals (TFFP)